- Trials with a EudraCT protocol (79)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (42)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: STATISTICAL RESULT OF A DOUBLE-BLIND COMPARATIVE TRIAL WITH LIORESAL VERSUS PLACEBO IN CEREBRAL PALSY IN CHILDREN |
| Active substance: BACLOFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22066 |
| Study title: Statistical result of a double-blind comparative trial with Lioresal versus placebo in cerebral palsy in children |
| Active substance: BACLOFEN |
| Study summary document link (including results): baclofen-LIR 647A NL10 Art45 listing 2011.xls |
| View full study record |
| Document reference: 22075 |
| Study title: STATISTICAL RESULT OF A DOUBLE-BLIND, BETWEEN-PATIENT COMPARATIVE TRIAL WITH LIORESAL VERSUS PLACEBO IN CEREBRAL PALSY IN CHILDREN |
| Active substance: BACLOFEN |
| Study summary document link (including results): baclofen-LIR 647A D85 Art45 listing 2011.xls |
| View full study record |
| Document reference: 22067 |
| Study title: STATISTICAL RESULT OF A DOUBLE-BLIND, BETWEEN-PATIENT COMPARATIVE TRIAL WITH LIORESAL VERSUS PLACEBO IN CEREBRAL PALSY IN CHILDREN |
| Active substance: BACLOFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22072 |
| Study title: Statistical result of a double-blind, between-patient comparative trial with Lioresal versus placebo in cerebral palsy in children |
| Active substance: BACLOFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22076 |
| Study title: STATISTICAL RESULT OF A DOUBLE-BLIND, WITHIN-PATIENT COMPARATIVE TRIAL WITH LIORESAL VERSUS PLACEBO IN CEREBRAL PALSY IN CHILDREN |
| Active substance: BACLOFEN |
| Study summary document link (including results): baclofen-LIR 647A DK11 Art45 listing 2011.xls |
| View full study record |
| Document reference: 22068 |
| Study title: Management of drooling in cerebral palsy: three single case studies. |
| Active substance: BENZATROPINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41946 |
| Study title: A multicentre, double-blind, prospective, randomised, placebo controlled phase II study to assess the efficacy and safety of botulinum toxin A (Dysport) in the treatment of adductor muscle spasticity in children with cerebral palsy (CP). |
| Active substance: Botulinum toxin A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22710 |
| Study title: A phase IV, Multicentre, Open, prospective study to evaluate the Efficacy & Tolerability of Dysport in the Treatment of Dynamic (non-fixed) Equinus Foot Deformity in young children with Cerebral Palsy |
| Active substance: Botulinum toxin A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22679 |
| Study title: Botulinum Toxin and Short-Term Electrical Stimulation in the Treatment of Equinus in Cerebral Palsy; Detrembleur et al |
| Active substance: Botulinum toxin A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22687 |
| Study title: Central and Peripheral Effects of Botulinum Toxin A in Children with Cerebral Palsy |
| Active substance: Botulinum toxin A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22692 |
| Study title: Parameters for predicting favourable responses to botulinum toxin in children with cerebral palsy; Fattal-Valevski et al |
| Active substance: Botulinum toxin A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22683 |
| Study title: A double-blind, prospective, randomised, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of Dysport with placebo in lower limb spasticity in children with cerebral palsy |
| Active substance: Botulinum toxin A; |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41068 |
| Study title: Mathew A, Mathew MC, Thomas M, Antonisamy B. The efficacy of diazepam in enhancing motor function in children with spastic cerebral palsy. J Trop Pediatr. 2005 Apr;51(2):109-13.Mathew A, Mathew MC, Thomas M, Antonisamy B. The efficacy of diazepam in enhancing motor function in children with spastic cerebral palsy. J Trop Pediatr. 2005 Apr;51(2):109-13. |
| Active substance: DIAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25940 |
| Study title: Mathew A, Mathew MC. Bedtime diazepam enhances well-being in children with spastic cerebral palsy. Pediatr Rehabil. 2005 Jan-Mar;8(1):63-6. Mathew A, Mathew MC. Bedtime diazepam enhances well-being in children with spastic cerebral palsy. Pediatr Rehabil. 2005 Jan-Mar;8(1):63-6. |
| Active substance: DIAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25941 |
| Study title: Botulinum Toxin and Short-Term Electrical Stimulation in the Treatment of Equinus in Cerebral Palsy; Detrembleur et al |
| Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24425 |
| Study title: Botulinum Toxin in Cerebral Palsy Upper Extremity Performance: A Placebo Controlled, Double Blind Study |
| Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24431 |
| Study title: Injections of Botulinum Toxin A in salivary glands in persons with cerebral palsy and a drooling problem. |
| Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24420 |
| Study title: Parameters for predicting favourable responses to botulinum toxin in children with cerebral palsy; Fattal-Valevski et al |
| Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24421 |
| Study title: The use of botulinum toxin type A in spastic diplegia due to cerebral palsy; Ward et al |
| Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24426 |
